138 related articles for article (PubMed ID: 35759452)
1. Death-Associated Protein Kinase 3 Inhibitors Identified by Virtual Screening for Drug Discovery in Cancer and Hypertension.
Xue B; Chaddha M; Elasbali AM; Zhu Z; Jairajpuri DS; Alhumaydhi FA; Mohammad T; Abdulmonem WA; Sharaf SE; Hassan MI
OMICS; 2022 Jul; 26(7):404-413. PubMed ID: 35759452
[TBL] [Abstract][Full Text] [Related]
2. Phytoconstituents and Medicinal Plants for Anticancer Drug Discovery: Computational Identification of Potent Inhibitors of PIM1 Kinase.
Anjum F; Mohammad T; Almalki AA; Akhtar O; Abdullaev B; Hassan MI
OMICS; 2021 Sep; 25(9):580-590. PubMed ID: 34448628
[TBL] [Abstract][Full Text] [Related]
3. Targeting Pim Kinases and DAPK3 to Control Hypertension.
Carlson DA; Singer MR; Sutherland C; Redondo C; Alexander LT; Hughes PF; Knapp S; Gurley SB; Sparks MA; MacDonald JA; Haystead TAJ
Cell Chem Biol; 2018 Oct; 25(10):1195-1207.e32. PubMed ID: 30033129
[TBL] [Abstract][Full Text] [Related]
4. De Novo Fragment Design for Drug Discovery and Chemical Biology.
Rodrigues T; Reker D; Welin M; Caldera M; Brunner C; Gabernet G; Schneider P; Walse B; Schneider G
Angew Chem Int Ed Engl; 2015 Dec; 54(50):15079-83. PubMed ID: 26486226
[TBL] [Abstract][Full Text] [Related]
5. Death-associated protein kinase 3 mediates vascular structural remodelling via stimulating smooth muscle cell proliferation and migration.
Usui T; Sakatsume T; Nijima R; Otani K; Kazama K; Morita T; Kameshima S; Okada M; Yamawaki H
Clin Sci (Lond); 2014 Oct; 127(8):539-48. PubMed ID: 24814693
[TBL] [Abstract][Full Text] [Related]
6. Structure-Guided Approach to Discover Tuberosin as a Potent Activator of Pyruvate Kinase M2, Targeting Cancer Therapy.
Adnan M; Shamsi A; Elasbali AM; Siddiqui AJ; Patel M; Alshammari N; Alharethi SH; Alhassan HH; Bardakci F; Hassan MI
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361954
[TBL] [Abstract][Full Text] [Related]
7. Bioactive Phytoconstituents as Potent Inhibitors of Tyrosine-Protein Kinase Yes (YES1): Implications in Anticancer Therapeutics.
Yang C; Alam A; Alhumaydhi FA; Khan MS; Alsagaby SA; Al Abdulmonem W; Hassan MI; Shamsi A; Bano B; Yadav DK
Molecules; 2022 May; 27(10):. PubMed ID: 35630545
[TBL] [Abstract][Full Text] [Related]
8. Structure-based investigation of MARK4 inhibitory potential of Naringenin for therapeutic management of cancer and neurodegenerative diseases.
Anwar S; Khan S; Shamsi A; Anjum F; Shafie A; Islam A; Ahmad F; Hassan MI
J Cell Biochem; 2021 Oct; 122(10):1445-1459. PubMed ID: 34121218
[TBL] [Abstract][Full Text] [Related]
9. Biophysical changes of ATP binding pocket may explain loss of kinase activity in mutant DAPK3 in cancer: A molecular dynamic simulation analysis.
Agarwal T; Annamalai N; Maiti TK; Arsad H
Gene; 2016 Apr; 580(1):17-25. PubMed ID: 26748242
[TBL] [Abstract][Full Text] [Related]
10. Searching for Novel Anaplastic Lymphoma Kinase Inhibitors: Structure-Guided Screening of Natural Compounds for a Tyrosine Kinase Therapeutic Target in Cancers.
Adnan M; Koli S; Mohammad T; Siddiqui AJ; Patel M; Alshammari N; Bardakci F; Elasbali AM; Hassan MI
OMICS; 2022 Aug; 26(8):461-470. PubMed ID: 35925819
[TBL] [Abstract][Full Text] [Related]
11. Integrated virtual screening and MD simulation study to discover potential inhibitors of Lyn-kinase: targeting cancer therapy.
Hassan MI; Anjum D; Mohammad T; Alam M; Khan MS; Shahwan M; Shamsi A; Yadav DK
J Biomol Struct Dyn; 2023 Dec; 41(20):10558-10568. PubMed ID: 36495308
[TBL] [Abstract][Full Text] [Related]
12. Identification of 11-Hydroxytephrosin and Torosaflavone A as Potential Inhibitors of 3-Phosphoinositide-Dependent Protein Kinase 1 (PDPK1): Toward Anticancer Drug Discovery.
Atiya A; Alhumaydhi FA; Sharaf SE; Al Abdulmonem W; Elasbali AM; Al Enazi MM; Shamsi A; Jawaid T; Alghamdi BS; Hashem AM; Ashraf GM; Shahwan M
Biology (Basel); 2022 Aug; 11(8):. PubMed ID: 36009858
[TBL] [Abstract][Full Text] [Related]
13. Identification and evaluation of bioactive natural products as potential inhibitors of human microtubule affinity-regulating kinase 4 (MARK4).
Mohammad T; Khan FI; Lobb KA; Islam A; Ahmad F; Hassan MI
J Biomol Struct Dyn; 2019 Apr; 37(7):1813-1829. PubMed ID: 29683402
[TBL] [Abstract][Full Text] [Related]
14. Identification of novel PI3Kδ inhibitors by docking, ADMET prediction and molecular dynamics simulations.
Liu YY; Feng XY; Jia WQ; Jing Z; Xu WR; Cheng XC
Comput Biol Chem; 2019 Feb; 78():190-204. PubMed ID: 30557817
[TBL] [Abstract][Full Text] [Related]
15. Molecular Network Analyses Implicate Death-Associated Protein Kinase 3 (DAPK3) as a Key Factor in Colitis-Associated Dysplasia Progression.
Chen HM; MacDonald JA
Inflamm Bowel Dis; 2022 Oct; 28(10):1485-1496. PubMed ID: 35604388
[TBL] [Abstract][Full Text] [Related]
16. A virtual screening investigation to identify bioactive natural compounds as potential inhibitors of cyclin-dependent kinase 9.
Atiya A; Shahidi H; Mohammad T; Sharaf SE; Abdulmonem WA; Ashraf GM; Elasbali AM; Alharethi SH; Alhumaydhi FA; Baeesa SS; Rehan M; Shamsi A; Shahwan M
J Biomol Struct Dyn; 2023 Nov; 41(19):10202-10213. PubMed ID: 36562191
[TBL] [Abstract][Full Text] [Related]
17. A multitier virtual screening study of phytoconstituents as Myeloid Cell Leukemias 1 inhibitors.
Liu W; Khalid M; Wahab S; Faizan Siddiqui M; Hasan Khan S; Sadiq M; Khatoon Z
J Biomol Struct Dyn; 2024 Jul; 42(10):5219-5228. PubMed ID: 37418235
[TBL] [Abstract][Full Text] [Related]
18. Activation of AKT negatively regulates the pro-apoptotic function of death-associated protein kinase 3 (DAPK3) in prostate cancer.
Das TP; Suman S; Papu John AM; Pal D; Edwards A; Alatassi H; Ankem MK; Damodaran C
Cancer Lett; 2016 Jul; 377(2):134-9. PubMed ID: 27126362
[TBL] [Abstract][Full Text] [Related]
19. Identification of mitogen-activated protein kinase 7 inhibitors from natural products: Combined virtual screening and dynamic simulation studies.
Alharbi B; Alnajjar LI; Alhassan HH; Khan S; Jawaid T; Abdullaev BS; Alshammari N; Yadav DK; Adnan M; Shamsi A
J Mol Recognit; 2024 Jan; 37(1):e3067. PubMed ID: 37956676
[TBL] [Abstract][Full Text] [Related]
20. Structure-Based Virtual Screening and Discovery of New Bi-functional DAPK1 Inhibitors.
Talwar P; Singh P; Ravanan P
Mol Biotechnol; 2024 Apr; 66(4):876-901. PubMed ID: 37351834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
